Nephrology and Renal Cancer Research

The University Hospital Olomouc is active in nephrology and oncology, with studies focused on kidney-related diseases and renal cell carcinoma. This research is mainly aimed at testing new treatment approaches, comparing them with standard care, and improving outcomes for people with advanced kidney disease and kidney cancer.

  • Advanced or metastatic renal cell carcinoma
  • Clear cell renal cancer
  • Primary membranous nephropathy
  • Alport syndrome

Work at this site also includes studies on kidney cancer recurrence prevention and better control of proteinuria and renal function in chronic kidney disorders.

Respiratory and Pulmonary Disease Trials

Research in respiratory diseases at University Hospital Olomouc covers both common and complex lung conditions. The trials are designed to evaluate new therapies, reduce symptoms, and improve breathing capacity and long-term disease control in patients with difficult-to-treat pulmonary disorders.

  • Idiopathic pulmonary fibrosis
  • Progressive pulmonary fibrosis
  • Severe asthma with an eosinophilic phenotype
  • Oral corticosteroid dependent asthma
  • Pulmonary sarcoidosis with or without extrapulmonary manifestations
  • Chronic lung allograft dysfunction after lung transplantation

These studies reflect a strong focus on lung function, inflammation, and treatment effectiveness in chronic respiratory disease.

Oncology Across Solid and Blood Cancers

The site conducts broad cancer research spanning solid tumors and hematologic malignancies. Many trials aim to improve survival, delay disease progression, and refine treatment choices for patients with advanced or hard-to-treat cancers.

  • Breast Cancer
  • Advanced epithelial ovarian cancer
  • Muscle Invasive Bladder Cancer
  • Esophageal carcinoma
  • Gastrointestinal stromal tumor
  • Acute lymphoblastic leukemia
  • Untreated Chronic Lymphocytic Leukemia
  • Newly Diagnosed Multiple Myeloma

Research here includes studies of immunotherapy, targeted therapy, and combination treatment strategies to better manage advanced malignancies.

Prostate and Urologic Oncology

Clinical trials in urologic oncology at this hospital focus on prostate and bladder cancers, with an emphasis on improving disease control and reducing the risk of progression or recurrence. The goal is to evaluate whether newer treatments can offer better outcomes than current standard approaches.

  • Prostate cancer
  • Oligometastatic prostate cancer
  • PSMA PET scan positive Castration-Resistant Prostate Cancer
  • Muscle Invasive Bladder Cancer

These studies highlight the use of precision imaging and advanced cancer therapies in men’s health and urinary tract cancers.

Immune-Mediated and Transplant-Related Conditions

The research portfolio also includes immune system diseases and transplant-related complications. Trials in this area are looking at safer and more effective ways to control inflammation, preserve organ function, and improve quality of life in chronic immune-driven conditions.

  • Pulmonary sarcoidosis
  • Primary membranous nephropathy
  • Lung transplant rejection

At University Hospital Olomouc, this work supports better management of autoimmune disease and post-transplant care through new therapeutic options.

Cardiovascular, Digestive, and Women’s Health Studies

Beyond cancer and kidney disease, the site is involved in trials across cardiovascular disease, digestive system disease, and women’s health. These studies are aimed at preventing major complications, easing symptoms, and improving day-to-day health in diverse patient groups.

  • Prevention of stroke or systemic embolism in atrial fibrillation
  • Esophageal carcinoma
  • Sleep disturbances associated with menopause

This mix of studies shows a broad interest in preventive care, symptom relief, and treatment effectiveness across several internal medicine specialties.

Inherited and Rare Disease Research

The clinical trial program at this hospital also reaches into congenital and hereditary diseases. These studies are especially important for patients with rare conditions, where research is often needed to find more targeted and better tolerated treatment options.

  • Alport syndrome
  • Congenital, hereditary, and neonatal diseases and abnormalities

Research in this field is focused on improving disease control, slowing progression, and expanding treatment possibilities for uncommon disorders.